Skip to main content
Tweets by AES2020
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Better Outcomes through Diveristy
Pediatric Highlights Poster
Partners Against Mortality in Epilepsy
Marco Rizzo, MD, PhD
Senior Medical Director, Clinical Development
(764) A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Natalizumab as Adjunctive Therapy in Adult Participants with Drug-Resistant Focal Epilepsy
Monday, December 7, 2020
9:00 AM – 10:30 AM US EST